Target intelligence / Profile preview

Liver-resident and infiltrating immune cells

Molecular classification
Other
01

Overview

Liver-resident and infiltrating immune cells represent the diverse immunological landscape of the liver, comprising both permanent residents and transiently recruited populations. Resident cells, such as Kupffer cells (KCs), liver-resident Natural Killer (lrNK) cells, and Mucosal-Associated Invariant T (MAIT) cells, are crucial for maintaining immune tolerance and rapid response to gut-derived antigens (Dixon et al., 2013, Comprehensive Physiology; Robinson et al., 2016, Cellular & Molecular Immunology). Infiltrating cells, including monocyte-derived macrophages, neutrophils, and various T-cell subsets, are recruited in response to injury, infection, or malignancy, often driving the progression of chronic liver diseases (Krenkel & Tacke, 2017, Nature Reviews Immunology). This collective population is central to the pathogenesis of non-alcoholic steatohepatitis (NASH), viral hepatitis, and hepatocellular carcinoma (HCC) (Ringelhan et al., 2018, Nature Reviews Gastroenterology & Hepatology). Pharmacological intervention typically involves targeting specific receptors or signaling pathways within these cells, such as CCR2/CCR5 inhibitors to block recruitment or checkpoint inhibitors to reinvigorate exhausted T cells (Tacke, 2017, Journal of Hepatology). Understanding the spatial and functional heterogeneity of these cells is vital for developing precision therapies that can resolve inflammation without compromising systemic immunity (Heymann & Tacke, 2016, Nature Reviews Gastroenterology & Hepatology).

Other names
Hepatic immune landscapeIntrahepatic immune cellsLiver immune microenvironmentHepatic immune cell population
02

Mechanism of action

Modulation of immune cell recruitment, activation, or exhaustion within the hepatic microenvironment (Tacke, 2017, Journal of Hepatology; Ringelhan et al., 2018, Nature Reviews Gastroenterology & Hepatology).

03

Biological functions

Immune responseTissue homeostasisAntigen presentationCytokine productionImmune surveillancePhagocytosis
04

Disease associations

InflammationCancerInfectionFibrosisNon-alcoholic steatohepatitis (NASH)Autoimmune hepatitis
05

Safety considerations

HepatotoxicityImmune-related adverse events (irAEs)Cytokine release syndromeSystemic immunosuppressionAutoimmune hepatitis
06

Interacting drugs

4 more in the full profile.

07

Biomarkers

CD68CD163CD3CD8CD56CD161Alanine aminotransferase (ALT)Aspartate aminotransferase (AST)

Beyond the preview

Go deeper on Liver-resident and infiltrating immune cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Liver-resident and infiltrating immune cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call